Stay ahead of developments in federal and state health care law, regulation and transactions with timely, expert news and analysis.
The FDA is waving goodbye to powdered medical gloves, banning them starting Jan. 18, 2017, because of risks to patients and health-care providers.
The Food and Drug Administration rarely uses its authority to ban devices. The agency’s ban on powdered medical gloves is only the second time it has banned a medical device. The first time was more than 33 years ago, when it banned prosthetic hair fibers.
Exposure to powdered latex gloves can cause unreasonable and substantial risk of illness or injury to patients and health-care providers, the final rule containing the ban, published Dec. 19 (81 Fed. Reg. 91,722), says.
A medical device ban completely prohibits current and future sales, distribution and manufacturing of a medical device. The FDA is authorized to ban a medical device intended for human use if it finds the device presents an unreasonable and substantial risk of illness or injury that can’t be corrected by changing the device’s labeling.
“Banning powdered glove products is not expected to impose any costs to society, but is expected to reduce the number of adverse events associated with using powdered gloves,” the agency said. “The primary public health benefit from adoption of the rule would be the value of the reduction in adverse events associated with using powdered gloves.”
Public Citizen, a public health advocacy organization, welcomed the final rule but criticized the agency for not acting to ban the gloves in 1998, when the group first called for a ban.
“The agency’s 18-year delay in acting to remove these dangerous products from the market represents reckless negligence,” Michael A. Carome, director of Public Citizen’s Health Research Group, told Bloomberg BNA Dec. 19.
“There is absolutely no new scientific information today that we didn’t have in 1998 about the dangers posed by cornstarch powder and by latex when used in surgical and patient examination gloves. And alternatives to powdered medical gloves have existed for decades,” Carome said.
“The FDA had the legal authority to ban powdered gloves in 1998. The agency should have used that authority to protect hundreds of thousands of hospital workers and patients who have been exposed to the powder. Had the FDA initiated the process of banning powdered medical gloves in 1998 instead of 18 years later, hundreds of thousands of health workers and patients would have been spared preventable, often life-threatening adverse reactions,” Carome said.
Bloomberg BNA also contacted the American Latex Allergy Association (ALAA), a group representing people with latex allergies, which supported the ban, for comment on the rule, but didn’t receive a response.
The Malaysian Rubber Export Promotion Council and the Trade Section of the Embassy of Malaysia in New York didn’t respond to Bloomberg BNA’s request for comment.Malaysia is the largest surgical and medical gloves supplier to the U.S. In fact, the value of glove exports reached $1.6 billion in 2015, according to the Malaysian embassy.
Banning powdered medical gloves “could eventually impair the competitiveness of our local players in the global rubber industry,” the embassy told the FDA in comments on the proposed rule earlier this year.
To contact the reporter on this story: Dana A. Elfin in Washington at email@example.com
To contact the editor responsible for this story: Brian Broderick at firstname.lastname@example.org
The final rule is available at http://src.bna.com/kQ8.
Copyright © 2016 The Bureau of National Affairs, Inc. All Rights Reserved.
All Bloomberg BNA treatises are available on standing order, which ensures you will always receive the most current edition of the book or supplement of the title you have ordered from Bloomberg BNA’s book division. As soon as a new supplement or edition is published (usually annually) for a title you’ve previously purchased and requested to be placed on standing order, we’ll ship it to you to review for 30 days without any obligation. During this period, you can either (a) honor the invoice and receive a 5% discount (in addition to any other discounts you may qualify for) off the then-current price of the update, plus shipping and handling or (b) return the book(s), in which case, your invoice will be cancelled upon receipt of the book(s). Call us for a prepaid UPS label for your return. It’s as simple and easy as that. Most importantly, standing orders mean you will never have to worry about the timeliness of the information you’re relying on. And, you may discontinue standing orders at any time by contacting us at 1.800.960.1220 or by sending an email to email@example.com.
Put me on standing order at a 5% discount off list price of all future updates, in addition to any other discounts I may quality for. (Returnable within 30 days.)
Notify me when updates are available (No standing order will be created).
This Bloomberg BNA report is available on standing order, which ensures you will all receive the latest edition. This report is updated annually and we will send you the latest edition once it has been published. By signing up for standing order you will never have to worry about the timeliness of the information you need. And, you may discontinue standing orders at any time by contacting us at 1.800.372.1033, option 5, or by sending us an email to firstname.lastname@example.org.
Put me on standing order
Notify me when new releases are available (no standing order will be created)